Jennison Associates »

Revance Therapeutics shares owned by Jennison Associates

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Jennison Associates from 13F filings

Historical chart of Jennison Associates investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Jennison Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Jennison Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.1M 1.0M 8.79
2023-09-30 $11M 998k 11.47
2023-06-30 $47M 1.8M 25.31
2023-03-31 $53M 1.6M 32.21
2022-12-31 $37M 2.0M 18.46
2022-09-30 $29M 1.1M 27.00
2022-06-30 $24M 1.8M 13.82
2022-03-31 $48M 2.4M 19.50
2021-12-31 $36M 2.2M 16.32
2021-09-30 $58M 2.1M 27.86
2021-06-30 $58M 1.9M 29.64
2021-03-31 $59M 2.1M 27.95
2020-12-31 $62M 2.2M 28.34
2020-09-30 $58M 2.3M 25.14
2020-06-30 $52M 2.1M 24.42
2020-03-31 $25M 1.7M 14.80
2018-09-30 $864k 35k 24.86
2018-06-30 $31M 1.1M 27.45
2018-03-31 $46M 1.5M 30.80
2017-12-31 $31M 858k 35.75
2017-09-30 $10M 378k 27.55
2017-06-30 $10M 378k 26.40
2015-09-30 $2.3M 78k 29.76
2015-06-30 $2.5M 78k 31.98
2015-03-31 $2.3M 109k 20.73
2014-12-31 $1.8M 109k 16.94
2014-09-30 $5.8M 299k 19.33
2014-06-30 $38M 1.1M 34.00
2014-03-31 $5.5M 175k 31.50